Share price
$0.60
As of Apr 28, 2026
CTXR | NASDAQ
Citius Pharmaceuticals, Inc.
Citius Pharmaceuticals, Inc. (CTXR) | runway -1.2 months | financing risk high | market cap $14.5M. Daily snapshot of financials, capital pressure, and recen...
Company websiteLast updated Apr 28, 2026
Market cap
$14.5M
Snapshot valuation
30D volume
694,951 shares
Rolling average daily volume
Runway
-1.2 months
Estimated from precomputed burn and cash
Financing risk
N/A
The company screens as likely to return to the capital markets soon.
Snapshot summary
Runway: -1.2 months based on estimated burn.
Recent financing detected on Apr 23, 2026.
Financing signal: The company screens as likely to return to the capital markets soon.
Recent developments
Citius Pharmaceuticals, Inc. 424B5 2026-04-24
424B5 filing submitted on 2026-04-24.
Citius Pharmaceuticals, Inc. 8-K 2026-04-24
8-K filed on 2026-04-24.
Citius Pharmaceuticals, Inc. 8-K 2026-04-06
8-K filed on 2026-04-06.
Citius Pharmaceuticals, Inc. 8-K 2026-03-31
8-K filed on 2026-03-31.
Citius Pharmaceuticals, Inc. 8-K 2026-03-10
8-K filed on 2026-03-10.
Related screens
Low cash runway companies
Companies screening with the shortest estimated runway based on precomputed burn and cash snapshots.
High burn rate companies
Companies with the highest estimated trailing cash burn across the monitored issuer set.
Recent financing disclosures
Companies with recent financing activity, capital raises, or post-balance-sheet funding events.
Pre-market filings
Companies with recent filings or disclosures posted before the market open.
Related companies
Recent documents
Citius Pharmaceuticals, Inc. 8-K 2026-04-24
8-K filed on 2026-04-24.
Apr 23, 2026Open source
Citius Pharmaceuticals, Inc. 424B5 2026-04-24
424B5 filing submitted on 2026-04-24.
Apr 23, 2026Open source
Citius Pharmaceuticals, Inc. 8-K 2026-04-06
8-K filed on 2026-04-06.
Apr 5, 2026Open source
Citius Pharmaceuticals, Inc. 8-K 2026-03-31
8-K filed on 2026-03-31.
Mar 30, 2026Open source
Premium analysis
Full filing analysis and proprietary signal detail
Detailed impact scoring, historical financial trends, full filing analysis, premium alerts, and proprietary signal explanations stay behind login and subscription.
Full filing analysis with event-level impact scoring
Historical financial trends and runway context
Detailed signal breakdowns and proprietary explanations
Premium alerts, filters, and watchlist workflows
Deeper financing and dilution analysis
Timeline context across filings and disclosures